Nature: Hallucinogenic drugs in Modern Medicine and Mental Health
Nature editor Noah Gray asked four neuroscience bloggers to write an opinion piece for the September issue of Nature Reviews Neuroscience, called "The neurobiology of psychedelic drugs: implications for the treatment of mood disorders." Here are the results:
Distorted perceptions and an altered state of mind: two reasons why psychedelics have always attracted not only fascination, but also controversy for decades. A recent Perspective in Nature Reviews Neuroscience entitled "The neurobiology of psychedelic drugs: implications for the treatment of mood disorders", by Franz Vollenweider & Michael Kometer explores why there is a renewed interest in the clinical potential of psychedelics for treating mental disorders, after nearly a 40 year gap in clinical experimentation. Anticipating a significant interest in this topic, Nature Publishing Group has made this manuscript freely accessible for 1 month. In addition, we offer a four-part series of essays by some of the best neuroscience bloggers to help you explore the literature and discuss the most important aspects:
1.) The secret history of psychedelic psychiatry by Moheb Costandi
2.) Serotonin, Psychedelics and Depression by Neuroskeptic
3.) Ketamine for Depression: Yea or Neigh? by The Neurocritic
4.) Visions of a psychedelic future by Vaughan Bell
[Thanks Mo!]
» More ways to bookmark this page
|
Recently @ DoseNation
|
|
The comments posted here do not reflect the views of the owners of this site.